Opyl preps key March quarter launch as the clinical trial recruitment market heats up

Opyl has been ticking a number of boxes as it gears up for the launch of its proprietary clinical trial recruitment platform in the March quarter.

For me it was important to achieve the cash flow positive milestone — ideally before we move into the stage of accelerating our clinical trial recruitment offering and company growth. It gives confidence to our shareholders, the market and clients to be able to see that, and also for our team inside the business. It illustrates that the company is managing its cash flow whilst continuing the development of exciting new platforms which will enable us to rapidly growth the company’s revenue and therefore company.” – Michelle Gallaher.

This is only an excerpt from an article written by Stockhead. The full version can be found here